NeoGenomics, Inc. Restricted Cash and Cash Equivalents
NeoGenomics, Inc. (NEO) had Restricted Cash and Cash Equivalents of $32.00 million as of 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-10-29
- 2020-09-30: Restricted Cash and Cash Equivalents $32.00M.
- 2020-06-30: Restricted Cash and Cash Equivalents $36.00M.
- 2020-03-31: Restricted Cash and Cash Equivalents $38.70M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-09-30 | $32.00M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $36.00M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $38.70M 10-Q · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |